E-LIB Suche - Ergebnisse für: Boerma, Annemarie

1

Profiling the SARS-CoV-2-specific T-cell response:

Geers, Daryl ; Gommers, Lennert ; Tan, Ngoc H...
The Lancet Infectious Diseases. 24 (2024) 8 - p. e477-e478 , 2024

2

SARS-CoV-2 Spike-specific IFN-γ T-cell Response After COVID..:

Imhof, Céline ; Messchendorp, A. Lianne ; van der Heiden, Marieke...
Transplantation Direct. 8 (2022) 11 - p. e1387 , 2022

Link: https://doi.org/10.1097/..

3

Re-polarization of immunosuppressive macrophages to tumor-c..:

Oyarce, Cesar ; Vizcaino-Castro, Ana ; Chen, Shipeng..
OncoImmunology. 10 (2021) 1 - p. , 2021

Link: https://doi.org/10.1080/..

4

First-in-Human Phase I Clinical Trial of an SFV-Based RNA R..:

Komdeur, Fenne L. ; Singh, Amrita ; van de Wall, Stephanie...
Molecular Therapy. 29 (2021) 2 - p. 611-625 , 2021

Link: https://doi.org/10.1016/..

5

Alphavirus-based hepatitis C virus therapeutic vaccines: ca..:

Koutsoumpli, Georgia ; Ip, Peng Peng ; Schepel, Ilona...
Therapeutic Advances in Vaccines and Immunotherapy. 7 (2019) - p. 251513551987467 , 2019

Link: https://doi.org/10.1177/..

6

A rationally designed combined treatment with an alphavirus..:

Draghiciu, Oana ; Boerma, Annemarie ; Hoogeboom, Baukje Nynke..
OncoImmunology. 4 (2015) 10 - p. e1029699 , 2015

Link: https://doi.org/10.1080/..

7

Alphavirus-based Vaccines Encoding Nonstructural Proteins o..:

Ip, Peng Peng ; Boerma, Annemarie ; Regts, Joke...
Molecular Therapy. 22 (2014) 4 - p. 881-890 , 2014

Link: https://doi.org/10.1038/..

8

Prognostic role of indoleamine 2,3-dioxygenase in endometri..:

de Jong, Renske A. ; Kema, Ido P. ; Boerma, Annemarie...
Gynecologic Oncology. 126 (2012) 3 - p. 474-480 , 2012

Link: https://doi.org/10.1016/..

9

Loss of HLA class I and mismatch repair protein expression ..:

de Jong, Renske A. ; Boerma, Annemarie ; Boezen, H. Marike...
International Journal of Cancer. 131 (2012) 8 - p. 1828-1836 , 2012

Link: https://doi.org/10.1002/..

10

Viral vector-based vaccines encoding multiple epitopes of H..:

Toos, Daemen ; Jan, Wilschut ; Hans, Nijman..
Frontiers in Immunology. 4 (2013) - p. , 2013

Link: https://doi.org/10.3389/..

11

Immunogenicity of bivalent omicron (BA.1) booster vaccinati..:

Tan, Ngoc H ; Geers, Daryl ; Sablerolles, Roos S G...
https://research.rug.nl/en/publications/a8e22d3d-ad25-42f1-93ea-baf1f04d9649. , 2023

Link: https://hdl.handle.net/1..

12

Immunogenicity after second and third mRNA-1273 vaccination..:

Oosting, Sjoukje F ; van der Veldt, Astrid A M ; Fehrmann, Rudolf S N...
https://research.rug.nl/en/publications/2fa86b3d-4f76-44d1-8288-ffcaa3e8c8b1. , 2022

Link: https://hdl.handle.net/1..

13

SARS-CoV-2 Spike-specific IFN-γ T-cell Response After COVID..:

Imhof, Céline ; Messchendorp, A. Lianne ; van der Heiden, Marieke...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584182/. , 2022

Link: http://www.ncbi.nlm.nih...

14

SARS-CoV-2 Spike-specific IFN-gamma T-cell Response After C..:

Imhof, Celine ; Messchendorp, A. Lianne ; van der Heiden, Marieke...
https://research.rug.nl/en/publications/cc936d46-c454-42a7-aa7c-ee5aff272ad6. , 2022

Link: https://hdl.handle.net/1..

15

First-in-Human Phase I Clinical Trial of an SFV-Based RNA R..:

Komdeur, Fenne L ; Singh, Amrita ; van de Wall, Stephanie...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7854293/. , 2021

Link: http://www.ncbi.nlm.nih...